BI Asset Management Fondsmaeglerselskab A S Purchases 10,951 Shares of Tenet Healthcare Corporation $THC

BI Asset Management Fondsmaeglerselskab A S boosted its holdings in shares of Tenet Healthcare Corporation (NYSE:THCFree Report) by 9.5% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 125,992 shares of the company’s stock after buying an additional 10,951 shares during the period. BI Asset Management Fondsmaeglerselskab A S owned approximately 0.14% of Tenet Healthcare worth $25,581,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently modified their holdings of THC. Boston Partners grew its holdings in shares of Tenet Healthcare by 95.0% during the second quarter. Boston Partners now owns 2,267,142 shares of the company’s stock worth $398,949,000 after purchasing an additional 1,104,500 shares in the last quarter. Ameriprise Financial Inc. lifted its position in Tenet Healthcare by 8.0% during the second quarter. Ameriprise Financial Inc. now owns 2,119,423 shares of the company’s stock valued at $373,020,000 after purchasing an additional 157,109 shares during the last quarter. Norges Bank bought a new position in shares of Tenet Healthcare in the 2nd quarter worth $206,981,000. AQR Capital Management LLC raised its position in shares of Tenet Healthcare by 28.0% during the 2nd quarter. AQR Capital Management LLC now owns 1,156,263 shares of the company’s stock valued at $200,224,000 after buying an additional 252,993 shares in the last quarter. Finally, Alliancebernstein L.P. grew its position in Tenet Healthcare by 375.7% in the second quarter. Alliancebernstein L.P. now owns 790,254 shares of the company’s stock worth $139,085,000 after acquiring an additional 624,125 shares in the last quarter. Hedge funds and other institutional investors own 95.44% of the company’s stock.

Tenet Healthcare News Summary

Here are the key news stories impacting Tenet Healthcare this week:

  • Positive Sentiment: Tenet announced it has regained ownership of Conifer in a transaction valued at about $1.9 billion, restoring full control of its revenue-cycle management business — a move that could boost margins, accelerate integration of Conifer’s technology and lift future earnings. Tenet regains ownership of Conifer in $1.9B deal
  • Positive Sentiment: Analysts (Zacks) expect Tenet to again beat EPS estimates — citing its recent surprise history and the company’s combination of revenue growth and margin drivers — which supports near-term upside if results confirm the optimism. Will Tenet (THC) Beat Estimates Again in Its Next Earnings Report?
  • Neutral Sentiment: Industry review pieces on ambulatory surgery centers provide broader sector context for Tenet’s outpatient strategy but are unlikely to move the stock by themselves. ASCs in 2025: A Year in Review
  • Negative Sentiment: Details about the Conifer/CommonSpirit buyback show a larger cash/consideration footprint (~$2.65B reported by HealthLeaders), raising questions about how the deal is financed and the potential impact on leverage and liquidity — a concern given Tenet’s existing debt-to-equity and capital intensity. This financing uncertainty likely pressured the stock despite the strategic upside. Tenet Healthcare details $2.65B in Conifer-CommonSpirit buy back

Insider Activity

In related news, Director Nadja West sold 2,178 shares of the company’s stock in a transaction that occurred on Monday, December 15th. The stock was sold at an average price of $197.47, for a total transaction of $430,089.66. Following the completion of the transaction, the director owned 28,480 shares in the company, valued at $5,623,945.60. This represents a 7.10% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 0.81% of the company’s stock.

Tenet Healthcare Price Performance

Shares of Tenet Healthcare stock opened at $190.80 on Thursday. The firm has a market cap of $16.77 billion, a PE ratio of 13.08, a price-to-earnings-growth ratio of 0.82 and a beta of 1.44. The company’s fifty day simple moving average is $199.33 and its two-hundred day simple moving average is $192.37. The company has a quick ratio of 1.64, a current ratio of 1.71 and a debt-to-equity ratio of 2.27. Tenet Healthcare Corporation has a 12-month low of $109.82 and a 12-month high of $222.82.

Wall Street Analysts Forecast Growth

THC has been the subject of several research analyst reports. TD Cowen reaffirmed a “buy” rating on shares of Tenet Healthcare in a research note on Wednesday, January 7th. UBS Group reaffirmed a “buy” rating on shares of Tenet Healthcare in a research note on Tuesday. Weiss Ratings raised shares of Tenet Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Monday, December 29th. JPMorgan Chase & Co. upped their price objective on shares of Tenet Healthcare from $200.00 to $230.00 and gave the company an “overweight” rating in a research note on Thursday, November 13th. Finally, Truist Financial reiterated a “buy” rating and issued a $240.00 target price (up previously from $225.00) on shares of Tenet Healthcare in a research report on Monday, November 3rd. One analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $233.88.

View Our Latest Analysis on Tenet Healthcare

Tenet Healthcare Profile

(Free Report)

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.

Featured Articles

Institutional Ownership by Quarter for Tenet Healthcare (NYSE:THC)

Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.